Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.86 USD | 0.00% | -7.46% | -36.95% |
05-09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.95% | 69.81M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.19% | 21.83B | |
-10.93% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- Canaccord Genuity Adjusts Price Target on BioXcel Therapeutics to $20 From $75, Keeps Buy Rating